Matthew Henn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Seres Therapeutics, Inc (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript

Seres Therapeutics, Inc (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Eric shaffKeay nakaeMarella thorellMatthew hennJohn newmanJeff jonesTess romeroCanaccord genuityTerri youngTed tenthoffPiper sandlerCarlo tanziNestle health scienceSeres therapeutics incHigh school dropoutHigh school graduation

Microbiome treatments are taking off

Faecal transplants are just the start of a new sort of medicine

San diegoUnited statesUnited kingdomCity ofEric pamerMatthew hennBernd schnablSimon goldenbergUniversity of chicagoUniversity of californiaEconomist newspaperDrug administrationGood manufacturing practiceSimply scienceMicrobiome medicineFaecal microbiota transplantation

Faecal transplants are just the start of a new sort of medicine

Microbiome treatments are taking off | Science & technology

San diegoUnited statesCity ofUnited kingdomMatthew hennBernd schnablEric pamerSimon goldenbergDrug administrationUniversity of chicagoUniversity of californiaGood manufacturing practiceVedanta biosciences

Seres Therapeutics, Inc (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript

Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.

Terri youngMatthew hennDavid arkowitzEdward tenthoffJoseph thomePiper sandlerKevin mannixEric shaffAmerican college of gastroenterologySeres therapeutics incNestle health scienceSeres therapeuticsCall transcript novemberSeres therapeutics third quarterResults conferenceRisk factors

Seres Therapeutics (MCRB) Reports SER-155 Phase 1b Cohort 1 Results Showing Successful Drug Bacteria Engraftment and Substantial Reduction in Pathogen Domination

Seres Therapeutics (MCRB) Reports SER-155 Phase 1b Cohort 1 Results Showing Successful Drug Bacteria Engraftment and Substantial Reduction in Pathogen Domination
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMatthew hennExchange commissionInternational bloodHealth scienceMarrow transplant researchAmerican health drugSeres therapeutics incWall streetChief medical officerStudy designChief scientific officerHematologic malignanciesMemorial sloan kettering cancer centerInfection protectionLooking statements